Caption Management’s Precigen PGEN Stock Holding History

Caption Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,100,000	Closed	-$4.6M	–	1939
2025 Q4	$4.6M	Sell	1,100,000 -2,297,500	-68%	-$8.89M	0.03%	545
2025 Q3	$11.2M	Buy	3,397,500 +3,297,500	+3,298%	+$9.31M	0.09%	252
2025 Q2	$142K	Buy	+100,000	New	+$142K	﹤0.01%	1293
2023 Q1	–	Sell	-200,000	Closed	-$304K	–	1438
2022 Q4	$304K	Hold	200,000	–	–	﹤0.01%	1000
2022 Q3	$423K	Hold	200,000	–	–	0.01%	1105
2022 Q2	$268K	Sell	200,000 -120,000	-38%	-$178K	﹤0.01%	1198
2022 Q1	$675K	Buy	+320,000	New	+$779K	0.01%	1088

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Caption Management's PGEN Position: Q2 2026 in Review

Caption Management increased its Precigen (PGEN) stake by 194% in Q2 2026, buying an estimated $2.56M and bringing the position to 900,000 shares worth $5.13M. The position accounts for 0.02% of the portfolio, ranked #575.

Caption Management first reported a position in PGEN in Q1 2020 and has held it in 11 quarters since. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

Caption Management held 900,000 shares of Precigen worth $5.13M as of Q2 2026.
Caption Management bought 593,384 Precigen shares in Q2 2026, an estimated $2.56M.
Precigen made up 0.02% of Caption Management's portfolio in Q2 2026, its #575 holding.
Caption Management first reported a position in Precigen in Q1 2020 and has held it in 11 quarters since.
210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.